Friday, July 1, 2022

Protein Engineering Market worth US$ 2.9 Billion 2024 with a CAGR of 15.80%

 The report "Global Protein Engineering Market, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Other Product Types), By Technology (Irrational Protein Design, and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030.

Key Highlights:

  • In June 2019, Thermo Fisher Scientific Launches powerful Invitrogen iBright 1500 imaging system for western blot and gel imaging.
  • In July 2019, Amgen and the University of Washington's Institute for Protein Design (IPD), which is revolutionizing its field of science by creating custom-designed proteins from scratch to improve human health, today announced a broad collaboration that will cover multiple projects with a goal of testing new technologies and creating protein-building approaches that can be broadly applied to the search for new medicines.

Analyst View:

The propelling factors for the growth of the global protein engineering market include the increasing prevalence of protein deficient diseases, increase in adoption of protein drugs over non-protein drugs. In addition, increased demand for alternatives to chemical processes, and rising government funding for protein engineering will further boost the growth of target market.  Factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies are expected to drive the growth of global protein engineering market.  There is a rising number of government initiatives, such as funding R&D for protein engineering and awareness programs, which have influenced the healthcare industry. The government is thus proactively investing in many of the research studies. For instance, Protein Technologies Ltd (PTL) has received funding from the UK government’s Technology Strategy Board (now Innovate UK) for its innovative research in protein engineering. Hence the increasing number of government initiatives for the efficient protein engineering research helps in driving the overall growth of the market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Protein Engineering Market”, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Other Product Types), By Technology (Irrational Protein Design, and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Key Market Insights from the report:        

The global Protein Engineering market accounted for US$ 2.9 billion by 2024 and is projected to register a moderate CAGR of 15.80% over the forecast period. The market report has been segmented on the basis of product type, technology, end user, and region.

  • By product type, monoclonal antibody accounted for a dominant share of the protein type segment and are anticipated to grow at a lucrative rate during the forecast period. Growing R&D expenditure in development of therapeutically advanced mAbs is presumed to be one of the significant factors responsible for increased adoption of these tools.
  • By technology, rational design dominated the technology segment with a share of over 39.0%. The dominant share can be attributed to extensive usage of this technology in antibody and enzyme engineering. 
  • By end user, Pharmaceutical & biotechnology companies held a dominant share in the end-use segment in 2016. The substantial share can be attributed to the increasing adoption of in silico models to develop new protein-based drugs in the following applications: cancer, diabetes, and central nervous system diseases.
  • By region, North America captured a dominant share of the market. Consistent number of collaborations encouraged by key market players for increasing their R&D capabilities are presumed to be responsible for the greater share captured by this region.

To know the upcoming trends and insights prevalent in this market, click the link below:

Links:

https://prophecymarketinsights.com/market_insight/Global-Protein-Engineering-Market-By-4118

Competitive Landscape:

The prominent player operating in the global Protein Engineering market includes Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Amgen Inc., Bruker Corporation, General Electric, PerkinElmer, Inc., Genscripts USA, Inc., and Sigma-Aldrich Corporation.  

The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

  • Explains an overview of the product portfolio, including product development, planning, and positioning
  • Explains details about key operational strategies with focus on R&D strategies, corporate structure, localization strategies, production capabilities, and sales performance of various companies
  • Detailed analysis of this XYZ market revenue in previous & next coming years
  • Examining various outlooks of the XYZ market with the help of Porter’s five forces analysis.
  • Study on the product type that is anticipated to dominate the XYZ market.
  • Study on the regions that are expected to register the fastest growth over the forecast period.

Key Topics Covered

  1. Introduction
  • Study Deliverables
  • Study Assumptions
  • Scope of the Study
  1. Research Methodology
  2. Executive Summary
  • Opportunity Map Analysis
  • Market at Glance
  • Market Share (%) and BPS Analysis, by Region
  • Competitive Landscape
  • Heat Map Analysis 
  • Market Presence and Specificity Analysis
  1. Investment Analysis
  2. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Wednesday, June 29, 2022

Insomnia Market is estimated to be US$ 6.13 billion by 2030 with a CAGR of 5.30% during the forecast period

 The Global Insomnia Market accounted for US$ 3.79 billion in 2020 and is estimated to be US$ 6.13 billion by 2030 and is anticipated to register a CAGR of 5.30%. Insomnia is a disorder characterized by lack of sleep or inability to sleep. People with insomnia often experience fatigue, low energy, difficulty concentrating, mood disturbances, and decreased performance overall. Insomnia-related conditions are caused due to disruption in circadian rhythm, chronic pain, hyperthyroidism, menopause, and psychological stress. Excessive use of drugs, such as caffeine, alcohol, and nicotine could also lead to insomnia.

The report “Global Insomnia Market By Therapy Type (Pharmacological Therapy and Non Pharmacological Therapy), By Drug Formulation (Capsules and Tablets), By Type of Diseases (Poor Quality of Sleep and Sleep Maintenance), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Key Highlights:

  • In 2017, The European Sleep Research Society has laid down guidelines for the diagnosis alongside the treatment of patients suffering from insomnia. The guidelines laid further talk about the use of light therapy and exercise that are seen as potential and useful getaways to treat insomnia. However, the evidence for the same is weak and low as of now.

Analyst View:

Surging number of insomnia patient across the globe is the primary factor driving the market. Technological advances in the treatment drugs are also fuelling the target market growth currently. In addition, increasing number of people working in shifts and stressful conditions is also supporting the global market growth. However, lack of education and awareness about the disorder is a major restraining factor for the growth of the market. Factors like presence of large undiagnosed insomnia population pool and untapped markets in developing economies present lucrative opportunities for the market growth.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Insomnia Market By Therapy Type (Pharmacological Therapy and Non Pharmacological Therapy), By Drug Formulation (Capsules and Tablets), By Type of Diseases (Poor Quality of Sleep and Sleep Maintenance), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030”

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/239

Key Market Insights from the report:

The Global Insomnia Market accounted for US$ 3.79 billion in 2020 and is estimated to be US$ 6.13 billion by 2030 and is anticipated to register a CAGR of 5.30%. The global insomnia market has been segmented into therapy type, drug formulation, type of diseases and region.

  • By Therapy type, the Global Insomnia Market is segmented into Pharmacological Therapy and Non Pharmacological Therapy.
  • By Drug Formulation, the Global Insomnia Market is segmented into Capsules and Tablets.
  • By Type of Diseases, the Global Insomnia Market is segmented into Poor Quality of Sleep and Sleep Maintenance.
  • By region, the Global Insomnia Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region is dominating the global market as it accounts for the highest percentage of insomnia-affected patients among all regions.

Competitive Landscape:

Key players operating in the global insomnia market include Eisai, Co., Pfizer, Inc., Merck & Co Inc., Sanofi SA, Takeda Pharmaceutical Company, Meda Consumer Healthcare Inc., Pernix Therapeutics, Purdue Pharma L.P., Consumer Healthcare Inc., and Dainippon Sumitomo Pharma Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

  • Explains an overview of the product portfolio, including product development, planning, and positioning
  • Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
  • Detailed analysis of the market revenue over the forecasted period.
  • Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
  • Study on the segments that are anticipated to dominate the market.
  • Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered

  1. Introduction
  • Study Deliverables
  • Study Assumptions
  • Scope of the Study
  1. Research Methodology
  2. Executive Summary
  • Opportunity Map Analysis
  • Market at Glance
  • Market Share (%) and BPS Analysis, by Region
  • Competitive Landscape
  • Heat Map Analysis 
  • Market Presence and Specificity Analysis
  1. Investment Analysis
  2. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Tuesday, June 28, 2022

Industrial Microbiology Market is estimated to be US$ 23.72 billion by 2030 with a CAGR of 7.50% during the forecast period

The report "Global Industrial Microbiology Market, By Product Type (Equipment & Systems, Consumables, and Reagents), By Application (Food & Beverage Industry, Pharmaceutical & Biotechnology Industry, Agricultural Industry, Environmental Industry, Cosmetic Industry or Personal Care Industry, and Other Application Areas), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030. The global industrial microbiology market accounted for US$ 11.53 billion in 2020 and is estimated to be US$ 23.72 billion by 2030 and is anticipated to register a CAGR of 7.50% . The global industrial microbiology market is large and growing due to an increasing preference for automation. The rising emphasis on industrial food and safety is driving the growth of the global market. Industrial microbiology has applications in cosmetics, agriculture, food and beverages, and pharmaceuticals. Moreover, demand for consumer products is growing with the rise in the population globally; the need for product safety and quality testing is also on the rise. Industrial microbiology tackles with the screening, enhancement, and controlling of microorganisms for the production of various end-use products. Fast and accurate testing of pathogens can reduce industry costs, protect brand image, and speed up the outbreak investigation and response. Growing consumer concerns and increasing product recalls are boosting the global industrial microbiology market. The fermentation of beer, wine, and cheese also require industrial microorganisms, thus fueling the target market growth.

Key Highlights:

  • In November 2018, BioMérieux acquired a majority stake in Hybiome and strengthens its presence, both in China and in the immunoassay market.
  • In March 2019, Thermo Fisher Scientific Inc. and Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, declared that it had entered into a definitive agreement, under which, Thermo Fisher will acquire Brammer Bio for approximately USD$ 1.7 billion in cash.

Key Market Insights from the report:        

The global industrial microbiology market accounted for US$ 11.53 billion in 2020 and is estimated to be US$ 23.72 billion by 2030 and is anticipated to register a CAGR of 7.50%. The market report has been segmented based on product type, application, and region.

  • By product type, the global market is segmented into equipment & systems, consumables, and reagents
  • By application, the pharmaceutical biotechnology application segment is expected to dominate the global market over the forecast period. This is mainly credited due to the presence of a large number of pharmaceutical companies developing and manufacturing novel drugs. The frequency of speedy drug approvals and drug innovation are also boosting the growth of the segment.
  • By region, North America dominates the global market and is expected to maintain its dominance over the forecast period. The U.S. industrial microbiology market is accounted to be driven, due to the rapid growth in various industries, like pharmaceutical, food and beverage, environmental, agricultural, and cosmetic. 

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Industrial Microbiology Market”, By Product Type (Equipment & Systems, Consumables, and Reagents), By Application (Food & Beverage Industry, Pharmaceutical & Biotechnology Industry, Agricultural Industry, Environmental Industry, Cosmetic Industry or Personal Care Industry, and Other Application Areas), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

To know the upcoming trends and insights prevalent in this market, click the link below:

Links:

https://prophecymarketinsights.com/market_insight/Global-Industrial-Microbiology-Market-By-3773

The prominent player operating in the global Industrial Microbiology market includes 3M Company, Becton Dickinson and Company, Agilent Technologies, Bio-Rad Laboratories, Inc., BioMerieux SA, Danaher Corporation, Eppendorf AG, Qiagen NV, Sigma Aldrich (Merck KGaA), and Thermo Fisher Scientific Inc.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions Development Company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Monday, June 27, 2022

Blockchain in Genomics Market is estimated to be US$ 3,881.2 million by 2029 with a CAGR of 66.42% during the forecast period

 The Global Blockchain in Genomics market accounted for US$ 37.9 million in 2020 and is estimated to be US$ 3,881.2 million by 2030 and is anticipated to register a CAGR of 66.42%. Genomic medicine enables accurate diagnosis, prognosis, and treatment of a variety of genetic disorders by using genetic data. An individual's genetic information is profiled using genomic techniques to assess disease susceptibility and suitable treatment strategies for their personalized medicine. Block chain is a block-based digital public ledger of transactions and records. Block chain creates a decentralized network of distributable data that can be shared between databases that are linked together. This technology allows users to monitor how their data is shared, preserving their privacy. Users can encrypt their data with asymmetric cryptography (Public Key Cryptography) for added protection.

The report " Global Blockchain in Genomics Market, By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model), By Service (Utility Tokens and Blockchain Platforms), By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:

  • Nebula Genomics revealed in September 2020 that it would collaborate with Oasis Labs to develop a new paradigm for the secure use of personal genomics data and to provide consumers with first-of-its-kind access to its genetic data.
  • Digital DNAtix Ltd launched the first free anonymous genetic vault service in September 2019.

Analyst View:

The market is being driven by the utility and demand for safe transactions involving specific genomic data. Furthermore, increased use of genomic data in clinical workflows is projected to fuel market growth over the forecasted timeframe. Digitalization of healthcare facilities and increased use of digital resources In the forecasted timeframe, it is expected to increase demand. Furthermore, increasing government funding for genomics is expected to boost the demand for blockchain in genomics in the near future.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Blockchain in Genomics Market, By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model), By Service (Utility Tokens and Blockchain Platforms), By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Blockchain-in-Genomics-Market-3751

Key Market Insights from the report:

The Global Blockchain in Genomics market accounted for US$ 37.9 million in 2020 and is estimated to be US$ 3,881.2 million by 2030 and is anticipated to register a CAGR of 66.42%. The Global Blockchain in Genomics Market is segmented based on the business model, service, application, and region.

  • By Business model, the Global Blockchain in Genomics Market is segmented into B2B business model, B2C business model and C2Bbusiness model.
  • By Service, the market is segmented in Utility tokens and Blockchain platforms
  • By Application, the Global Blockchain in Genomics Market is segmented into data sharing & monetization, data storage & security and Automated health Insurance.
  • By Region, the Global Blockchain in Genomics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Because of its rich economy and the presence of numerous research firms in the area, North America retained the majority of market share. 

Competitive Landscape:

The key players operating in the Global Blockchain in Genomics Market include Encrypgen Incorporated Digital DNAtix Ltd., Genomes.io, Genobank.io Inc., Longenesis, Nebula Genomics, Inc., LunaDNA, LLC, Shivom Ventures Limited, WuXi Nextcode Genomics, Inc., SimplyVital Health, Inc., Zenome.io, Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

  • Explains an overview of the product portfolio, including product development, planning, and positioning
  • Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
  • Detailed analysis of the market revenue over the forecasted period.
  • Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
  • Study on the segments that are anticipated to dominate the market.
  • Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered

  1. Introduction
  • Study Deliverables
  • Study Assumptions
  • Scope of the Study
  1. Research Methodology
  2. Executive Summary
  • Opportunity Map Analysis
  • Market at Glance
  • Market Share (%) and BPS Analysis, by Region
  • Competitive Landscape
  • Heat Map Analysis 
  • Market Presence and Specificity Analysis
  1. Investment Analysis
  2. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Sunday, June 26, 2022

Drug Device Combination Products Market is estimated to be US$ 277.9 billion by 2030 with a CAGR of 7.8% during the forecast period

 The report "Global Drug Device Combination Products Market, By Product (Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, and Insulin), Orthopedic Combination Products (Bone Graft Implants and Antibiotic Bone Cement), Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Stents (Coronary Stents and Peripheral Vascular Stents), Wound Care Products, Inhalers (Dry Powder, Nebulizers, and Metered Dose), Antimicrobial Catheters (Urological, Cardiovascular, and Others), and Others. By Wound Type (Cardiovascular Disease, Diabetes, Respiratory Problem, Cancer Treatment, Antimicrobial Application, and Other Applications (Neurological, Skin Treatments, Etc.)), By End-User (Hospital and Clinic, Ambulatory Surgery Center (ASC), and Home Care Setting), and Region - Global Forecast to 2030" The Global Drug Device Combination Product Market accounted for US$ 130.4 billion in 2020 and is estimated to be US$ 277.9 billion by 2030 and is anticipated to register a CAGR of 7.8%. Physician and patients gives preference for minimally invasive procedures and consistent-dosing treatment alternatives drives the global drug device combination products market. Further, rising incidences of chronic diseases such as hyper tension, obesity, cancer, and diabetes is expected to boost the global drug device combination products market.

Key Highlights:

  • On 12 April 2019, Cipla Limited launched “Niveoli” inhaler, is a new product combination formulations and drug-device combinations in the respiratory therapy.

Key Market Insights from the report:          

The Global Drug Device Combination Product Market accounted for US$ 130.4 billion in 2020 and is estimated to be US$ 277.9 billion by 2030 and is anticipated to register a CAGR of 7.8%. The market report has been segmented on the basis of product, wound type, end-user, and region.

  • By product, the transdermal patch segment is accounted for major share in the global drug device combination products market. This can be attributed to rising demand for self-administration of drugs in cases of diseases requiring long-term treatment.
  • By wound type, the global drug device combination products market is segmented into cardiovascular disease, diabetes, respiratory problem, cancer treatment, antimicrobial application, and other. Others sub-segment is divided into neurological, skin treatments, etc.
  • By end-user, the global drug device combination products market has been segmented into hospital and clinic, ambulatory surgery center (ASC), and home care setting.
  • By region, North America drug device combination products market is expected to account for major share in terms of revenue in the global drug device combination products market over the forecast period. This can be attributed to increasing prevalence of chronic diseases, coupled with prominent players pour their efforts for launching new product in countries of the region. Asia Pacific drug device combination products market is expected to account for significant share in terms of revenue in the target market in the near future.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Drug Device Combination Products Market”, By Product (Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, and Insulin), Orthopedic Combination Products (Bone Graft Implants and Antibiotic Bone Cement), Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Stents (Coronary Stents and Peripheral Vascular Stents), Wound Care Products, Inhalers (Dry Powder, Nebulizers, and Metered Dose), Antimicrobial Catheters (Urological, Cardiovascular, and Others), and Others. By Wound Type (Cardiovascular Disease, Diabetes, Respiratory Problem, Cancer Treatment, Antimicrobial Application, and Other Applications (Neurological, Skin Treatments, Etc.)), By End-User (Hospital and Clinic, Ambulatory Surgery Center (ASC), and Home Care Setting), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)- forecast till 2029

To know the upcoming trends and insights prevalent in this market, click the link below:

Links

https://www.prophecymarketinsights.com/market_insight/Global-Drug-Device-Combination-Products-707

The prominent player operating in the global drug device combination products market include Abbott Laboratories, Terumo Corporation, Stryker Corporation, Mylan N.V., Medtronic plc, Allergan plc, Boston Scientific Corporation, Novartis AG, Becton Dickinson, and Cipla Limited. 

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Thursday, June 23, 2022

Interventional Cardiology Devices Market is estimated to be US$ 11.31 billion by 2030 with a CAGR of 7.50% during the forecast period.

Interventional Cardiology Devices Market accounted for US$ 5.50 billion in 2020 and is estimated to be US$ 11.31 billion by 2030 and is anticipated to register a CAGR of 7.50%. Interventional cardiology may be a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Many procedures are often performed on the guts by catheterization. This most ordinarily involves the insertion of a sheath into the arteria femoralis (but, in practice, any large peripheral artery or vein) and cannulating the guts under X-ray visualization (most commonly fluoroscopy). The arteria radialis can also be used for cannulation; this approach offers several advantages, including the accessibility of the artery in most patients, the straightforward control of bleeding even in anticoagulated patients, the enhancement of comfort because patients are capable of sitting up and walking immediately following the procedure, and therefore the near absence of clinically significant sequelae in patients with a traditional Allen test.

The report " Global Interventional Cardiology Devices Market, By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis, and Forecast till 2030”

Key Highlights:

  • In 2020, Edward Lifesciences Corporation (US) has received Chinese regulatory approval for the SAPIEN 3 Transcatheter Heart Valve for the treatment of patients affected by severe, symptomatic stenosis (AS) who are unable to undergo heart surgery
  • In 2019, Medtronic (US) has received US FDA approval for its Next-Generation Evolut PRO TAVR System for the treatment of symptomatic severe stenosis in patients

Analyst View:

Rising prevalence of lifestyle habits like a growing number of smokers, rising incidence rates of obesity, and dietary irregularities are liable for the expansion within the prevalence of major cardiovascular diseases across the planet fuelling interventional cardiology device industry growth. Each year, 170,000 people die from heart and circulatory diseases within the UK. Such a huge patient population and therefore the high death rate is predicted to extend the demand for interventional cardiology devices within the coming years.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Interventional Cardiology Devices Market, By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis, and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Interventional-Cardiology-Devices-Market-721

Key Market Insights from the report:

Global Interventional Cardiology Devices Market accounted for US$ 5.50 billion in 2020 and is estimated to be US$ 11.31 billion by 2030 and is anticipated to register a CAGR of 7.50%.The Global Interventional Cardiology Devices Market is segmented into types, and region.

  • On the basis of type, the Global Interventional Cardiology Devices Market is segmented into Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Other.
  • Based on region the Global Interventional Cardiology Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to hold dominating position in the Global Interventional Cardiology Devices Market during the forecast period.

Competitive Landscape:

The Key players in the global interventional cardiology devices market includes, Cordis Corporation, Abbott Laboratories, Medtronic, Inc., Terumo Medical Corporation, Braun Melsungen AG, Boston Scientific Coprporation, Terumo Corporation, Cordis Corporation, Biosensors International Group, Ltd., and Biotronik, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

  • Explains an overview of the product portfolio, including product development, planning, and positioning
  • Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
  • Detailed analysis of the market revenue over the forecasted period.
  • Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
  • Study on the segments that are anticipated to dominate the market.
  • Study on the regional analysis that is expected to register the highest growth over the forecast period 

Key Topics Covered

  1. Introduction
  • Study Deliverables
  • Study Assumptions
  • Scope of the Study
  1. Research Methodology
  2. Executive Summary
  • Opportunity Map Analysis
  • Market at Glance
  • Market Share (%) and BPS Analysis, by Region
  • Competitive Landscape
  • Heat Map Analysis 
  • Market Presence and Specificity Analysis
  1. Investment Analysis
  2. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.co

Plastic Injection Molding for Medical Device Market is estimated to be US$ 148.88 million by 2030 with a CAGR of 6.1% during the forecast period

 The Global Plastic Injection Molding for Medical Device Market accounted for US$ 82.7 million in 2020 and is estimated to be US$ 148.88 million by 2030 and is anticipated to register a CAGR of 6.1%. The medical plastic injection molding process is cost-efficient, and ideal for top volume production runs and applications requiring consistency and tight tolerances. This molding process is additionally used for medical device prototype development for the FDA approval process and to be used in laboratory testing. Since inception, the utilization of plastics within modern medicine has steadily increased. Medical devices that are manufactured from injection molded plastic have contributed to a discount in medical costs, communicable disease and pain management. High tech polymers are used within medical device prototype development and are commonly wont to create improved artificial limbs and devices that reduce the danger of infection. Medical plastic injection molding directly results in increased patient safety and therefore the ability to save lots of more lives. Since medical device plastics provide increased versatility and may be combined with metal to make enhanced medical product attributes, medical grade plastics became the well-liked material for varied sorts of electronic medical devices.

The report “Global Plastic Injection Molding for Medical Device Market, By Product Type (Drug Delivery Products, Diagnostic Drug Test Kits, Package and Container, Surgical Consumables), By End User (Hospitals, clinics and R&D), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Key Highlights:

  • In Jan 2020, Comar and iMARK molding entered into an agreement with a purpose to serve the medical device industry and their acquisition focused on delivering best-in-class engineering and custom plastic molding to Comar’s medical devices customers.

Analyst View:

Increasing technological advancements in plastic injection molding techniques to make sure medical products are free from contamination and safer is additionally expected to drive the expansion of the respective market. Rising healthcare expenditure and spending in both developing and developed economies are among the crucial factors anticipated to bolster the worldwide plastic injection molding for the medical device market. Moreover, the growing global geriatric population, including the prevalence of chronic diseases, is another factor expected to fuel market growth.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Plastic Injection Molding for Medical Device Market, By Product Type (Drug Delivery Products, Diagnostic Drug Test Kits, Package and Container, Surgical Consumables), By End User (Hospitals, clinics and R&D), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Plastic-Injection-Molding-for-2593

Key Market Insights from the report:

The Global Plastic Injection Molding for Medical Device Market accounted for US$ 82.7 million in 2020 and is estimated to be US$ 148.88 million by 2030 and is anticipated to register a CAGR of 6.1%. The global plastic injection molding for medical device market report segments the market on the basis of type, end-user, and region.

  • Based on type, the Global Plastic Injection Molding for Medical Device Market is segmented into the Drug Delivery Products, Diagnostic Drug Test Kits, Package and Container, Surgical Consumables.
  • Based on end-user, the Global Plastic Injection Molding for Medical Device Market is segmented into Hospitals, clinics and R&D.
  • By region, the Global Plastic Injection Molding for Medical Device Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the Global Plastic Injection Molding for Medical Device Market owing to rising geriatric population.

Competitive Landscape:

The Key players in the global plastic injection molding for medical device market include Boston Scientific, SMC Plastics Ltd., CandJ Industries, Eastek International, Merit Medical, JunoPacific Inc., QFC Plastics, PCE Inc, Spectrum Plastics Group, Inc, Electroplast.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

  • Explains an overview of the product portfolio, including product development, planning, and positioning
  • Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
  • Detailed analysis of the market revenue over the forecasted period.
  • Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
  • Study on the segments that are anticipated to dominate the market.
  • Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered

  1. Introduction
  • Study Deliverables
  • Study Assumptions
  • Scope of the Study
  1. Research Methodology
  2. Executive Summary
  • Opportunity Map Analysis
  • Market at Glance
  • Market Share (%) and BPS Analysis, by Region
  • Competitive Landscape
  • Heat Map Analysis 
  • Market Presence and Specificity Analysis
  1. Investment Analysis
  2. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.co

Protein Engineering Market worth US$ 2.9 Billion 2024 with a CAGR of 15.80%

  The report  " Global Protein Engineering Market, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Facto...